Inventor · disambiguated record
George W. Muller
Also filed as: MULLER GEORGE · MULLER GEORGE W
172 granted patents·46 pending applications·9,624 citations·filing 1987–2022
99Inventor score
Top patents by PatentIndex Score
218 records- 0199US7893101B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2008·Granted Feb 22, 2011·44 cites·15 claims
- 0299US6555554B2Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2001·Granted Apr 29, 2003·245 cites·17 claims
- 0399US6476052B1Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2000·Granted Nov 5, 2002·295 cites·28 claims
- 0499US6403613B11-oxo-and 1,3-dioxoisoindolinesFiled 2000·Granted Jun 11, 2002·258 cites·20 claims
- 0599US6335349B1Substituted 2(2,6-dioxopiperidin-3-yl)isoindolinesCELGENE CORP·Filed 2000·Granted Jan 1, 2002·301 cites·23 claims
- 0699US6316471B1Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2000·Granted Nov 13, 2001·334 cites·26 claims
- 0799US6281230B1Isoindolines, method of use, and pharmaceutical compositionsCELGENE CORP·Filed 2000·Granted Aug 28, 2001·400 cites·26 claims
- 0899US5929117AImmunotherapeutic agentsCELGENE CORP·Filed 1997·Granted Jul 27, 1999·319 cites·11 claims
- 0999US5877200ACyclic amidesCELGENE CORP·Filed 1997·Granted Mar 2, 1999·351 cites·33 claims
- 1099US5874448ASubstituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 1997·Granted Feb 23, 1999·285 cites·23 claims
- 1199US5798368ATetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 1996·Granted Aug 25, 1998·305 cites·8 claims
- 1299US5698579ACyclic amidesCELGENE CORP·Filed 1996·Granted Dec 16, 1997·345 cites·35 claims
- 1398US7855217B2Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2008·Granted Dec 21, 2010·42 cites·10 claims
- 1498US7635700B25-Substituted quinazolinone derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2007·Granted Dec 22, 2009·78 cites·16 claims
- 1598US7465800B2Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2004·Granted Dec 16, 2008·87 cites·14 claims
- 1698US7427638B2(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereofCELGENE CORP·Filed 2005·Granted Sep 23, 2008·53 cites·13 claims
- 1798US7244759B2Isoindoline compounds and methods of making and using the sameCELGENE CORP·Filed 2004·Granted Jul 17, 2007·138 cites·6 claims
- 1898US7091353B2Isoindole-imide compounds, compositions, and uses thereofCELGENE CORP·Filed 2001·Granted Aug 15, 2006·147 cites·15 claims
- 1998US6962940B2(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereofCELGENE CORP·Filed 2003·Granted Nov 8, 2005·107 cites·23 claims
- 2098US6458810B1Pharmaceutically active isoindoline derivativesMULLER GEORGE·Filed 2000·Granted Oct 1, 2002·281 cites·18 claims
- 2198US6395754B1Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 1998·Granted May 28, 2002·296 cites·12 claims
- 2298US6380239B1Substituted 1-oxo- and 1,3-dioxoisoindoline and method of reducing inflammatory cytokine levelsCELGENE CORP·Filed 2000·Granted Apr 30, 2002·253 cites·18 claims
- 2398US6020358ASubstituted phenethylsulfones and method of reducing TNFα levelsCELGENE CORP·Filed 1998·Granted Feb 1, 2000·296 cites·19 claims
- 2498US5955476ASubstituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levelsCELGENE CORP·Filed 1998·Granted Sep 21, 1999·267 cites·23 claims
- 2598US5605914AImidesCELGENE CORP·Filed 1994·Granted Feb 25, 1997·152 cites·32 claims
- 2697US9499514B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2015·Granted Nov 22, 2016·28 cites·29 claims
- 2797US8518972B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameMAN HON-WAH·Filed 2011·Granted Aug 27, 2013·74 cites·7 claims
- 2897US8455536B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dioneMULLER GEORGE W·Filed 2009·Granted Jun 4, 2013·28 cites·56 claims
- 2997US8158653B2Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindolineMULLER GEORGE W·Filed 2006·Granted Apr 17, 2012·39 cites·2 claims
- 3097US7659302B2Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2008·Granted Feb 9, 2010·35 cites·20 claims
- 3197US6200987B1Cyclic amidesCELGENE CORP·Filed 2000·Granted Mar 13, 2001·52 cites·16 claims
- 3297US6011050ASubstituted phenethylsulfones and method of reducing TNFα levelsCELGENE CORP·Filed 1999·Granted Jan 4, 2000·172 cites·16 claims
- 3397US5635517AMethod of reducing TNFα levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolinesCELGENE CORP·Filed 1996·Granted Jun 3, 1997·643 cites·10 claims
- 3496US9018243B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2013·Granted Apr 28, 2015·13 cites·21 claims
- 3596US8093283B2Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2010·Granted Jan 10, 2012·17 cites·42 claims
- 3696US7820697B2Compositions and method for reducing TNFα levelsCELGENE CORP·Filed 2005·Granted Oct 26, 2010·27 cites·2 claims
- 3796US7709502B2Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolinesCELGENE CORP·Filed 2006·Granted May 4, 2010·24 cites·3 claims
- 3896US7659303B2Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2008·Granted Feb 9, 2010·21 cites·14 claims
- 3996US7507759B2Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dioneCELGENE CORP·Filed 2007·Granted Mar 24, 2009·21 cites·11 claims
- 4096US7358272B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2005·Granted Apr 15, 2008·21 cites·17 claims
- 4196US7208516B2Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2006·Granted Apr 24, 2007·40 cites·18 claims
- 4296US5801195AImmunotherapeutic aryl amidesCELGENE CORP·Filed 1994·Granted Sep 1, 1998·121 cites·16 claims
- 4395US9828361B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2016·Granted Nov 28, 2017·12 cites·10 claims
- 4495US8802717B2Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2012·Granted Aug 12, 2014·13 cites·22 claims
- 4595US8629173B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2011·Granted Jan 14, 2014·11 cites·39 claims
- 4695US8153659B24′-O-substituted isoindoline derivatives and compositions comprising and methods of using the sameRUCHELMAN ALEXANDER L·Filed 2008·Granted Apr 10, 2012·30 cites·21 claims
- 4795US8012997B2Isoindole-imide compounds, compositions, and uses thereofCELGENE CORP·Filed 2009·Granted Sep 6, 2011·30 cites·8 claims
- 4895US7994327B2Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compoundsCELGENE CORP·Filed 2006·Granted Aug 9, 2011·28 cites·13 claims
- 4995US7977357B2Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindo1-2-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2008·Granted Jul 12, 2011·16 cites·17 claims
- 5095US7629360B2Methods for the treatment of cachexia and graft v. host diseaseCELGENE CORP·Filed 2005·Granted Dec 8, 2009·21 cites·5 claims
Showing the top 50 of 218 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when George W. Muller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →